Morgan Stanley initiated coverage of Accelerant (ARX) with an Equal Weight rating and $28 price target The firm says the company is benefitting from the shift of risk into specialty markets with a risk exchange platform. However, Accelerant’s current valuation reflects most of its growth opportunities, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant Holdings Class A: Strong Buy Rating Driven by Strategic Positioning and Growth Potential in Specialty Insurance
- Accelerant initiated with an Outperform at RBC Capital
- Accelerant initiated with an Overweight at Piper Sandler
- Accelerant initiated with a Market Perform at Citizens JMP
- Accelerant initiated with a Neutral at Goldman Sachs